Next Biomedical Co.,Ltd. (389650.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩28,000 (+3.13%) as of
Key statistics
- Market cap
- 231.76B
- Forward P/E
- 50.27
- Dividend yield
- 0.00%
- 52-week range
- 25,150.00 – 101,000.00
- Beta
- -0.78
- Revenue (TTM)
- 17.79B
- Profit margin
- 1.31%
- Analyst target
- ₩87,666.66
- Volume
- 24.46k
About Next Biomedical Co.,Ltd.
Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Incheon, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.